Home › Funds › Octagon Capital Advisors LP › PHVS

Octagon Capital Advisors LP position in PHVS

PHARVARIS N V · Health Care

Octagon Capital Advisors LP reported holding 249,000 shares of PHVS (PHARVARIS N V) in its Q3 2026 13F filing — a position valued at US$7.9M, representing 1.05% of its reported portfolio and ranking #18 among its reported holdings. Octagon Capital Advisors LP has disclosed PHVS holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)249.00K sh
Reported value held$7.90M
Portfolio Weight1.05%
First reportedQ3 2024
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Octagon Capital Advisors LP's PHVS position evolved

Octagon Capital Advisors LP first disclosed a stake in PHVS in Q3 2024 at 620,470 shares (US$11.5M). The position peaked in Q4 2025 at 671,465 shares, worth US$18.6M. Across 9 filings, Octagon Capital Advisors LP increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 249,000 shares valued at US$7.9M — a reduction of -207,721 shares quarter over quarter.. Notable position changes include a 75% trim in Q1 2026 (shares rose 22% over the following quarter), a 177% increase in Q2 2026 (shares fell 8% over the following quarter), a 45% trim in Q3 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 620.47K $11.49M New
Q4 2024 778.00K $14.91M Add
Q1 2025 769.82K $12.09M Reduce
Q2 2025 672.60K $11.84M Reduce
Q3 2025 722.60K $18.03M Add
Q4 2025 671.47K $18.63M Reduce
Q1 2026 165.00K $4.66M Reduce
Q2 2026 456.72K $15.79M Add
Q3 2026 249.00K $7.90M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PHVS and 13F data

PHVS (PHARVARIS N V) is a Health Care company. 48 other funds we track also report a position in PHVS — the largest reported positions include Foresite Capital Management IV, LLC (US$151.6M), venBio Partners LLC (US$141.4M), EQT Fund Management S.a r.l. (US$108.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PHVS

All PHVS fund holders →

FAQ

How long has Octagon Capital Advisors LP held PHVS?

Octagon Capital Advisors LP has disclosed PHVS holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Octagon Capital Advisors LP's current position in PHVS?

As of Q3 2026, Octagon Capital Advisors LP holds 249.00K shares of PHVS (PHARVARIS N V), valued at $7.90M, representing 1.05% of its reported portfolio and ranking #18.

Has Octagon Capital Advisors LP been buying or selling PHVS?

In the latest 13F filing (Q3 2026), Octagon Capital Advisors LP reduced its position in PHVS. The position peaked in Q4 2025 at 671.47K shares.

Which other funds hold PHVS?

Other major institutional holders of PHVS include Foresite Capital Management IV, LLC, venBio Partners LLC, EQT Fund Management S.a r.l., among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.